Home › Trial NCT03122444
Imipramine on ER+ve and Triple Negative Breast Cancer
- Trial IDNCT03122444
- StatusCompleted
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorThe University of Texas Health Science Center at San Antonio
- Enrollment17
- Start date2019-07-05
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.